Synthesis of related substances of olmesartan medoxomil, an anti-hypertensive drug
Karrothu Srihari Babu, Amirisetty Ravindranath Tagore, G. Saikiran Reddy, Gandu Venkateswarlu, Padi Pratap Reddy, Ramasamy Vijaya Anand
Abstract
Open-access reader
Karrothu Srihari Babu, Amirisetty Ravindranath Tagore, G. Saikiran Reddy, Gandu Venkateswarlu, Padi Pratap Reddy, Ramasamy Vijaya Anand
Abstract
Open-access reader
Olmesartan medoxomil 1 is the latest angiotensin receptor antagonist approved by the FDA for the treatment of hypertension.During the process development of olmesartan medoxomil, four related substances (impurities) were observed along with the final API.Those impurities were identified as olmesartan acid, 4-acetyl olmesartan, 5-acetyl olmesartan, and dehydro olmesartan.Present work describes the synthesis and characterization of all these four impurities.
OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Olmesartan medoxomil 1 is the latest angiotensin receptor antagonist approved by the FDA for the treatment of hypertension.During the process development of olmesartan medoxomil, four related substances (impurities) were observed along with the final API.Those impurities were identified as olmesartan acid, 4-acetyl olmesartan, 5-acetyl olmesartan, and dehydro olmesartan.Present work describes the synthesis and characterization of all these four impurities.
Key concepts: Olmesartan, Chemistry, Pharmacology, Drug, Antagonist, Angiotensin II receptor antagonist, Angiotensin receptor, Angiotensin II